-+ 0.00%
-+ 0.00%
-+ 0.00%

EIKON THERAPEUTICS - TO INITIATE PHASE 1/2 ARGATE-001 STUDY FOR EIK1006 IN METASTATIC PROSTATE CANCER

Reuters·11/17/2026 11:02:23